Page last updated: 2024-10-25

ciglitazone and Dermatitis, Irritant

ciglitazone has been researched along with Dermatitis, Irritant in 1 studies

ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.

Dermatitis, Irritant: A non-allergic contact dermatitis caused by prolonged exposure to irritants and not explained by delayed hypersensitivity mechanisms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mao-Qiang, M1
Fowler, AJ1
Schmuth, M1
Lau, P1
Chang, S1
Brown, BE1
Moser, AH1
Michalik, L1
Desvergne, B1
Wahli, W1
Li, M1
Metzger, D1
Chambon, PH1
Elias, PM1
Feingold, KR1

Other Studies

1 other study available for ciglitazone and Dermatitis, Irritant

ArticleYear
Peroxisome-proliferator-activated receptor (PPAR)-gamma activation stimulates keratinocyte differentiation.
    The Journal of investigative dermatology, 2004, Volume: 123, Issue:2

    Topics: Animals; Cell Differentiation; Dermatitis, Irritant; Epidermis; Female; Filaggrin Proteins; Homeosta

2004